Article Text
Neurological rarities
Guanidinoacetate methyltransferase (GAMT) deficiency: a rare but treatable epilepsy
Abstract
Epilepsy commonly presents in childhood as part of a syndrome, and some such children may reach adult services without an underlying syndromic diagnosis. For adult neurologists taking over their care, it is often unclear how hard to search for an underlying diagnosis. The diagnostic yield may be small and such a diagnosis may not change management. Young adults with learning difficulties are also challenging to investigate, as they may not tolerate standard epilepsy tests.
We present such a case in which simple tests identified a unifying diagnosis. With the new diagnosis came a new treatment that had a significant impact on seizures and quality of life.
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- P19 Clinical pearl: pharmaceutical management of siblings with guanidinoacetate methyltransferase (gamt) deficiency
- Phenotype and genotype in 101 males with X-linked creatine transporter deficiency
- GP223 Creatine deficiency disorders the all-ireland experience
- Neurodegenerative disorders and metabolic disease
- Investigating adults with early-onset epilepsy and intellectual or physical disability
- POE05 A low creatinine in developmental delay, epilepsy and movement disorders—does it matter?
- Creatine transporter deficiency, an underdiagnosed cause of male intellectual disability
- 4CPS-188 Galenic preparations and rare diseases: guanidinoacetate methyltransferase deficiency: experience in a local hospital
- PFN2 and GAMT as common molecular determinants of axonal Charcot-Marie-Tooth disease
- Highlights from this issue